✦ LIBER ✦

Optimisation of TNF-Inhibitor Therapy for Rheumatoid Arthritis: Focus on Certolizumab Pegol

✍ Scribed by Lyseng-Williamson, Katherine A.; Duggan, Sean T.; Keating, Gillian M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS46 Cost-Utility Analysis of Certolizu

✍ R. Villoro; A. Hidalgo; B. Ferro; P. Talavera 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

BL1 COST-EFFECTIVENESS, VALUE OF INFORMA

✍ EJ Soini; T Hallinen; M Taiha; V Honkanen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

A Pharmacodynamic Markov Mixed-Effects M

✍ Lacroix, B D; Lovern, M R; Stockis, A; Sargentini-Maier, M L; Karlsson, M O; Fri 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 319 KB

The effects of TNF-alpha inhibitor thera

✍ Mathieu, Sylvain; Couderc, Marion; Pereira, Bruno; Soubrier, Martin 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Budget impact model of rituximab after f

✍ Robert Launois; Stéphanie Payet; Nathalie Saidenberg-Kermanac'h; Camille Frances 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 302 KB

Long-Term Benefits Over More Than 4 Year

✍ Kavanaugh, A.; Smolen, J.S.; Emery, P.; Keystone, E.; Strand, V.; Purcaru, O.; v 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB